Skip to main content
Signal8

Tucker John H

SEC insider (Form 3/4/5 filer). CIK 0001303480. President and CEO at scPharmaceuticals Inc. (SCPH). 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 7, 2025. Located in BURLINGTON, MA.

Companies Tucker John H has filed insider reports for

  • scPharmaceuticals Inc. (SCPH): Director, Officer, President and CEO
Tucker John H profile photo

Tucker John H

CIK: 0001303480

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (75.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

scPharmaceuticals Inc. logo
SCPH

scPharmaceuticals Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • scPharmaceuticals Inc. logo
    SCPH

    scPharmaceuticals Inc.

    Oct 7, 2025
    Tender Offer
    Direct
    122.3K shares-
  • scPharmaceuticals Inc. logo
    SCPH

    scPharmaceuticals Inc.

    Oct 7, 2025
    Disposition
    Direct
    318.5K shares-
  • scPharmaceuticals Inc. logo
    SCPH

    scPharmaceuticals Inc.

    Feb 11, 2025
    Award
    Direct
    200K shares-
  • scPharmaceuticals Inc. logo
    SCPH

    scPharmaceuticals Inc.

    Jan 3, 2025
    Tax Payment
    Direct
    13.4K shares at avg. $3.56$48K

1-4 of 4